Delivery Order SPE2DB22D9316-SPE2DB24FYP91

Award Date 8/9/24
Potential Completion Date 8/30/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,974.44 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $14,923.32 firm fixed-price delivery order for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The delivery order has a period of performance through March 22, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,846.64 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,509.56 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance ending on November 29, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $4,974.44 for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,495.90 firm fixed-price delivery order is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,855.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,117.20 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance through May 30, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,308.30 firm fixed-price delivery order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a period of performance through August 30, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP91
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,872.20 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, with a performance period through August 30, 2024.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. This contract award, which does not have a set-aside designation, is issued against that larger IDC vehicle to provide a specific pharmaceutical item.

Generated 11/8/24, 9:11 AM